Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Distribution and Morphology of Calcium-Binding Proteins Immunoreactive Neurons following Chronic Tungsten Multielectrode Implants

  • Marco Aurelio M. Freire,

    Affiliation Edmond and Lily Safra International Institute of Neurosciences (ELS-IIN), Santos Dumont Institute, Macaiba, RN, Brazil

  • Jean Faber,

    Affiliation Laboratory of Neuroengineering, Department of Science and Technology, Federal University of São Paulo (UNIFESP), Sao Jose dos Campos, SP, Brazil

  • Nelson Alessandretti M. Lemos,

    Current address: Stress Research Institute, Stockholm University, SE-106 91, Stockholm, Sweden

    Affiliation Edmond and Lily Safra International Institute of Neurosciences (ELS-IIN), Santos Dumont Institute, Macaiba, RN, Brazil

  • Jose Ronaldo Santos,

    Affiliation Laboratory of Neuroscience, Department of Biosciences, Federal University of Sergipe (UFS), Itabaiana, SE, Brazil

  • Pedro França Cavalcanti,

    Affiliation Edmond and Lily Safra International Institute of Neurosciences (ELS-IIN), Santos Dumont Institute, Macaiba, RN, Brazil

  • Ramon Hypolito Lima,

    Affiliation Memory Studies Laboratory, Department of Physiology, Federal University of Rio Grande do Norte (UFRN), Natal, RN, Brazil

  • Edgard Morya

    edgard@isd.org.br

    Affiliations Edmond and Lily Safra International Institute of Neurosciences (ELS-IIN), Santos Dumont Institute, Macaiba, RN, Brazil, Associação Alberto Santos Dumont para Apoio a Pesquisa, Sirio-Libanes Hospital, São Paulo, SP, Brazil

Distribution and Morphology of Calcium-Binding Proteins Immunoreactive Neurons following Chronic Tungsten Multielectrode Implants

  • Marco Aurelio M. Freire, 
  • Jean Faber, 
  • Nelson Alessandretti M. Lemos, 
  • Jose Ronaldo Santos, 
  • Pedro França Cavalcanti, 
  • Ramon Hypolito Lima, 
  • Edgard Morya
PLOS
x

Abstract

The development of therapeutic approaches to improve the life quality of people suffering from different types of body paralysis is a current major medical challenge. Brain-machine interface (BMI) can potentially help reestablishing lost sensory and motor functions, allowing patients to use their own brain activity to restore sensorimotor control of paralyzed body parts. Chronic implants of multielectrodes, employed to record neural activity directly from the brain parenchyma, constitute the fundamental component of a BMI. However, before this technique may be effectively available to human clinical trials, it is essential to characterize its long-term impact on the nervous tissue in animal models. In the present study we evaluated how chronic implanted tungsten microelectrode arrays impact the distribution and morphology of interneurons reactive to calcium-binding proteins calbindin (CB), calretinin (CR) and parvalbumin (PV) across the rat’s motor cortex. Our results revealed that chronic microelectrode arrays were well tolerated by the nervous tissue, with recordings remaining viable for up to 6 months after implantation. Furthermore, neither the morphology nor the distribution of inhibitory neurons were broadly impacted. Moreover, restricted microglial activation was observed on the implanted sites. On the whole, our results confirm and expand the notion that tungsten multielectrodes can be deemed as a feasible candidate to future human BMI studies.

Introduction

Neuropathological conditions, such as brain and spinal cord injuries, are currently the leading causes of disabilities worldwide, affecting severely the life of its sufferers [15] and imposing a significant socioeconomic burden to the health care system [6,7]. One of the main medical challenges in this field deals with the development of therapies capable of ensuring a better quality of life for those suffering from devastating levels of body paralysis. Any solution provided, however, has to face the major challenge of reestablishing both sensory and motor functions lost after a brain lesion. Brain-machine interfaces (BMI), which provide a new way for establishing direct communication between the brain and an external device, such as computers and robotic limbs [8,9], offers such a possibility.

Chronic multielectrodes implants define the fundamental component of an invasive BMI. Their use ensures an accurate assessment of the neuronal activity in awake, behaving animals [1012], representing a key tool for enhancing our general understanding of the neurophysiological principles that underlie the interactions of large populations of neurons. Nevertheless, before microwire arrays can be effectively available to human clinical trials, it is necessary to characterize their impact on the nervous tissue in animal models, particularly in the cortex. In this prospect, investigation becomes even more relevant when considering that one of the most essential prerequisite for any invasive BMI is its capability to remains functional through many years after the surgery for implantation of recording probes. Such longevity should maximize both the recording of stable high quality action potentials from hundreds to thousands of neurons and the preservation of the tissue surrounding the implant. This latter goal is critical if one intends to avoid structural and physiological alterations of brain tissue that could compromise the device’s performance and further complicate the patient’s neurological state.

The basic functions of the brain result from dynamic interactions among distinct groups of neurons [1315], ultimately emerging as all sort of refined cognitive functions and complex behaviors we are able to perform, including the aptitude to control a robotic prosthesis [16]. According to their physiological properties, there are two major groups of neurons: (I) excitatory cells, the main class of neurons (mostly represented by the pyramidal cells), that use glutamate as their chief neurotransmitter and approximately corresponds to 75–80% of the entirety of neurons [17], and (II) inhibitory interneurons (also known as local circuit neurons), corresponding to the remaining 20–25%, which can be defined as cells whose somas, axons and dendrites are entirely located inside the cerebral cortex [18]. The main feature of this latter cell group is the establishment of connections only with nearby neurons. As such, interneurons act as modulators of local cortical circuits [19]. γ-aminobutyric acid (GABA) is the chief neurotransmitter of inhibitory interneurons, which, in turn, are represented by a quite diverse population of cells, with distinct morphological, neurochemical and physiological features [20]. Immunohistochemistry for the calcium-binding proteins (CBP) calbindin (CB), calretinin (CR), and parvalbumin (PV) reveals the existence of morphologically heterogeneous classes of GABAergic interneurons, which are involved in a variety of complex cortical circuits, depending on cortical area or layer where they are located [21].

In a previous study we characterized some aspects of the impact caused by tungsten microelectrode arrays in the motor cortex of chronically implanted rats [22]. Here, we set out to extend our tissue analysis, evaluating the general distribution and morphology of the CBP-reactive neurons in the rat’s motor cortex following chronic multielectrode array implant. As an accessory data, we also aimed to characterize the level of inflammatory response induced by chronic presence of electrodes through a selective microglial marker (Iba1), since these cells are directly involved in the regulation and maintenance of the nervous system homeostasis [23]. Furthermore, we evaluated some aspects concerning the temporal variation of electrophysiological signals in function of signal-to-noise ratio (SNR) obtained during chronic cortical recordings, comparing data from first and last week of recording in all time points analyzed (1, 3 and 6 months of implantation).

Material and Methods

Animals and experimental design

Fifteen adult brains of male Wistar rats (320±20g) were used. All experimental procedures were in strict accordance with the NIH Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80–23), approved by Institutional Review Board (IDs # 04/2009 and 13/2011), and under the knowledge and agreement of Scientific Direction of ELS-IIN. All efforts were made to avoid any animal suffering and to reduce the number of subjects used.

The present study follows the same proposal adopted in our previous report concerning a suitable understanding on the impact of multielectrodes arrays in the rat’s brain [22]. Accordingly, the experimental design was quite similar. In brief, surgeries for multielectrode implantation were performed in rats deeply anesthetized with 100 mg/kg of ketamine chlorhydrate and 5 mg/kg xylazine chlorhydrate (i.p.). The animals were placed in a stereotaxic head holder, and a small craniotomy was made over the implant target area (primary motor cortex) (Fig 1). Each animal was slowly implanted with multielectrode arrays, manufactured as follows: Insulated tungsten wires (50-μm microwire diameter, 1.5 MOhm at 1.0 KHz, California Fine Wire Co., Grover Beach, CA, USA; Catalog number #100211, IS coating) were cut into 32, 5-cm segments. Each wire was soldered into separate slots in an Omnetics connector (Omnetics Connector Corp., Minneapolis, MN, USA) using a digital soldering station with a micro soldering pencil (Weller WD1, 0.25mm tip) in order to assemble an array of 4x8, with 500 μm spacing (Fig 1). The tip of the electrode was cut with a stainless steel precision surgical scissor, being visualized in a surgical magnifier (Zeiss Stemi 2000 Stereo Microscope, Carl Zeiss, Göttingen, Germany). The array was subsequently implanted in the motor cortex using the following coordinates (in millimeters relative to bregma): 0.5–4.0, anteroposterior (AP); 1.5–3.0, mediolateral (ML); 1.8–2.0, dorsoventral (DV) [24]. Stainless steel screws and dental acrylic were used to hold the implant. The ground stainless steel wire was soldered to a screw. After 7 days to surgical recovery, animals started to be recorded weekly. Three survival time groups were then defined, according to the total time of recording: 1, 3, and 6 months after initial implantation.

thumbnail
Fig 1. Multielectrode apparatus, coordinates adopted to implant and surgical procedure.

(a). General aspect of a 32 channel microelectrode array. (b). Details of the electrode array being implanted through the skull window on primary motor cortex, relative to bregma (marked with a black dot). Scale bars: 3.5 mm (a and b).

https://doi.org/10.1371/journal.pone.0130354.g001

Electrophysiological recordings

A 32-channel multi-neuron acquisition processor (MAP, Plexon Inc., Dallas, TX, USA) was used for spike recording and sorting in a weekly basis, for 30–45 min in rats freely behaving in their cages. Online spike sorting was conducted with the help of the SortClient 2002 software (Plexon Inc., USA). A maximum of 4 neuronal action potentials per channel were sorted online and validated by offline analysis (Offline Sorter 2.8, Plexon Inc., USA) according to some criteria, as previously described [22]: voltage thresholds, amplitude distributions, signal-to-noise ratio, waveform shapes, and principal component analysis. The temporal variation of the electrophysiological pattern in each group during its time of implant (increase or decrease of neural signal) was evaluated by comparing neural signal collected in first and last week of recording.

Perfusion and tissue processing

After the last recording section for each group, animals were deeply anesthetized with 5% isofluorane, overdosed with sodium thiopental (90 mg/kg) and then perfused intracardially with 0.9% warm heparinized saline (Roche Pharmaceuticals, NJ, USA) (2ml/1000ml) followed by 4% cold paraformaldehyde in 0.1M phosphate buffer (PB), pH 7.4 (Sigma Company, St Louis, MO, USA). Brains were then removed from the skull and immersed in 20% sucrose in 0.1M PB for 12h. The tissue was then frozen in a embedding medium (Tissue Tek, Sakura Finetek, Japan) and sectioned in the coronal plane at 30μm in a cryostat (Carl Zeiss Microm HM 550, Jena, Germany). The resulting sections were mounted on electrically charged glasses (Super Frost Plus–VWR International, Radnor, PA, USA) and submitted to immunohistochemistry to CBP as follows: sections were pre-incubated in a 1% hydrogen peroxide solution in methanol during 20 minutes to remove endogenous peroxidase activity, being then rinsed in 0.05% phosphate buffer-Tween (PB-T) for 5 minutes and incubated in 10% horse normal serum (diluted in 0.1M PB; Vector Laboratories, Burlingame, CA, USA) for 30 minutes in order to block non-specific binding. After, sections were incubated during 16h in CB, CR and PV primary antibodies (1:1000, diluted in 1% horse normal serum; Swant, Bellinzona, Switzerland) at 18°C, washed in PB-T by 6 minutes (2x, 3min each), incubated with a biotinylated horse anti-mouse secondary antibody (1:200, diluted in 0.1M PB; Vector Laboratories, Burlingame, CA, USA) for 2 h, washed in PB-T during 10 minutes (2x, 5min each), and then incubated in avidin-biotin-peroxidase solution (Vectastain Standard ABC kit, Vector Laboratories, USA) for 1h. Slides were then placed in a solution containing 0.03% 3,3’ diaminobenzidine tetrahydrochloride (DAB) (Sigma Company, USA) and 0.001% hydrogen peroxide in 0.1M PB, dehydrated through a series of graded alcohols and coverslipped with Entellan (Merck, Darmstadt, Germany). Further, some sections were immunostained using fluorescent labels, in which horse normal serum was replaced by 10% goat normal serum, and the secondary biotinylated antibody was replaced by Alexa Fluor 488-conjugated goat anti-mouse secondary antibody (1:700, diluted in 1% goat normal serum; Invitrogen, Grand Island, NY, USA) for 2h. In order to certify the specificity of the labeling the primary antibodies were replaced by normal serum in some randomly selected sections. CB, CR and PV are monoclonal antibodies that react specifically with parts of its target protein (the first 4 EF-hands domains in calretinin, the calbindin D-28k and the 45Ca-binding spot of parvalbumin) that are present only in neurons, not cross-reactive with glial cells.

To reveal the general pattern of microglial activation around each microelectrode’s implant site, additional sections were stained to Iba1 using fluorescent labels (Iba 1 is a protein specifically expressed in microglial cells, not cross-reactive with neurons and astrocytes). In brief, sections were washed during 10 minutes in PB-T and pre-incubated in 10% goat normal serum during 30 minutes. Thereafter, the sections were incubated during 24h with Iba1 primary antibody (1:500, diluted in 1% goat normal serum; Wako, Osaka, Japan) at 18°C. Sections were then washed in 0.1M PB during 5 minutes and incubated with Alexa Fluor 555-conjugated goat anti-rabbit secondary antibody (1:700, diluted in 1% goat normal serum; Invitrogen, Grand Island, NY, USA) for 2h. Finally, the sections were mounted using Vectashield mounting medium for fluorescence (Antifade solution) (Vector Laboratories, USA).

Some sections were dehydrated and mounted as previously described and stained with cresyl violet (Nissl staining) to identify the exact location of the electrode tracks.

Qualitative and quantitative analysis

For qualitative analysis, digital images were obtained with a CX9000 camera (MBF Biosciences, USA) attached to an optical microscope (Nikon Eclipse 80i, Tokyo, Japan- 10x and 20x objectives). Fluorescent images were obtained in a Carl Zeiss Laser Scanning Microscope (LSM 710, 10x and 40x objectives, Carl Zeiss, Jena, Germany). The contrast, and/or brightness of pictures were adjusted using Photoshop CS6 software (Adobe Systems Inc., San José, CA, USA).

To evaluate quantitatively the distribution of CBP-reactive neurons, we counted the total number of cells labeled by all markers (CB, CR and PV) in the region around electrode tracks in the three survival time groups (1, 3 and 6 months of implant) using the Neurolucida system (MBF Biosciences Inc., Williston, VT, USA). For each marker, we quantified 3 sections per animal, sampling tissue from regions where the electrode tracks could be unequivocally observed, covering 500μm of tissue in the anteroposterior axis. The cell density (cells/mm2) was estimated using an automatic grid from the Neurolucida program. The hemisphere contralateral to the implant was adopted as an intrinsic control in all animals. For the statistical comparison among groups we used both a non-parametric Kruskal-Wallis test and Spearman correlation followed by the Bonferroni post hoc test with significance level set at 95% (α = 0.05). Average values were referred to as mean ± standard error of the mean (SEM). When expressed in boxplots, the values were presented as median values with indication of the 25th to 75th percentiles.

Electrophysiological signal analysis

The yield of electrophysiological signals recorded from chronically implanted microwire arrays was assessed by comparing the total number of neuronal units observed in the first and last recording sessions of a given period (1, 3, or 6 months). In addition, in order to measure the quality of these recordings we evaluated the signal-to-noise ratio (SNR), a measure employed to compares the level of a well-defined neural signal to the level of background noise. The SNR was calculated using the equation 20*log10 (RMS[corr_signal/corr_surrogate]), where corr_signal corresponds to the auto-correlation of the temporal signal of each neuron given by the firing rate matrix (binned with 1 second) and corr_surrogate corresponds to the cross-correlation of temporal signal and its surrogate, which was generated by using a random shuffling of the firing rate matrices columns based on an uniform distribution (RMS: Root Mean Square) [25,26]. After the SNR measurement for each neuron, the average value in every group (1, 3 and 6 months of signal recording) was then calculated. For each animal there was an average and a standard deviation of the SNR. The standard deviation was used as a threshold to digitalize the SNR—for every point above the std was considered as “1” and every point below std was considered as “0”. Adopting this procedure we were able to eliminate possible spurious variations and emphasize on the main differences among the groups.

Furthermore, in order to evaluate the degree of signal quality, we defined six different thresholds based in the strength of the signal obtained on Plexon MAP box: 0 (no signal); 0.2; 0.4; 0.6; 0.8; and 1 (maximum SNR ratio). Neurons presenting a signal with a SNR index, as measured through the abovementioned formula, higher than 0.5 were considered of good quality. This procedure was applied in every group of animals (1, 3 and 6 months of recording), allowing us to evaluate the signal quality of the recorded units over time. Mean and variance were calculated using the standard deviation as threshold (SNR>std(SNR) = 1; and SNR<std(SNR) = 0) in Matlab 2008 software (The MathWorks Inc., Natick, MA, USA).

Results

Quality of the electrophysiological signal over time

There was an increase in SNR after 3 months of implant as compared to 1 month of implantation (Fig 2). In latter survival time (6 months after the array implant), there was a trend towards a decrease in the recording quality as compared to 3 months survival time, although a good SNR could still be obtained (Fig 2A). We also evaluated the temporal variation of the neuronal number in each group during its time of implantation, comparing the first and the last week of implant in all survival times. There was an improvement of the number of neuronal units recorded 3 months after implant as compared to 1 month of implant. In latter survival time (6 months of implant) the number of recorded cells decreased (Fig 2B).

thumbnail
Fig 2. Signal-to-noise ratio (SNR) of cortical neurons recorded from all animals across distinct survival times.

(a). Measurement of the SNR average among all time points revealed an increase in this parameter after 3 months of implant as compared to 1 month of implantation. In latter survival time (6 months after the array implant), quality of recordings decreased as compared to previous time point, though a good SNR still had been identified (standard deviation threshold: SNR>std(SNR) = 1; and SNR<std(SNR) = 0) (n = 5 animals by time point); values expressed as mean ± SEM. (b). Temporal variation of the neuronal number in each group during its time of implant, comparing the first and the last week of array implantation in all survival times, in relationship to Threshold rate (Hz) adopted to assess SNR (see Material and Methods). There was an improvement in the number of neuronal units from 1 month to 3 months of implant. In latter survival time (6 months of implant) number of recorded cells decreased (n = 5 animals by time point).

https://doi.org/10.1371/journal.pone.0130354.g002

General aspect of implant sites

The precise location of the microwire array implants was identified in all animals at all survival times (Fig 3). Nissl staining revealed a minimal tissue loss in the implant site, restricted to the exact location of electrodes, with preservation of cell bodies near the microelectrode track and the absence of vacuolization, an event usually observed after milieu alterations (Fig 3).

thumbnail
Fig 3. General pattern of implant sites.

(a). Nissl staining shows the well-defined location of the electrode track (arrow), revealing a small loss of tissue. (b). It was possible to attest the absence of vacuolization and pyctonic profiles in all time points evaluated. The tissue around electrode implants presented a similar aspect to their contralateral counterpart. Black squares in lower magnification pictures indicate the regions where enlargements were obtained in all groups. Left column of the figure: implanted hemisphere; right column of the figure: contralateral hemisphere, adopted as control. Scale bar: 100 μm (lower magnification); 200 μm (enlargements).

https://doi.org/10.1371/journal.pone.0130354.g003

Neuronal distribution across implanted sites

In general, the distribution of both CBP-reactive neurons in the implanted tissue was similar to those seen in its contralateral counterpart, except in the exact location of electrode track, where a small loss of tissue can be noticed (arrows in Fig 4).

thumbnail
Fig 4. Calcium-binding proteins immunoreactivity across implanted sites.

Chronic presence of electrodes did not affect the general cell distribution of calbindin (CB)- (a), calretinin (CR)- (b) and parvalbumin (PV)- (c) reactive neurons even after 6 months of implant. Left column of the figure: implanted hemisphere (arrows point to electrode tracks); right column of the figure: contralateral hemisphere, adopted as control. Scale bar: 100 μm.

https://doi.org/10.1371/journal.pone.0130354.g004

Calbindin-reactive neurons (CB) were found distributed across all layers of the motor cortex except in layer I, but more noticeably across layers II and III, with the pattern of cell body labeling varying from weakly to intensely reactive. The neuropil across supragranular layers was more intensely reactive than in other layers, revealing the labeling of extended, vertically oriented bundles of immunoreactive processes. Both their general morphology and distribution were not affected by electrode implant (Fig 4A).

Calretinin-reactive neurons (CR) were mainly concentrated across supragranular layers (except layer I), although some cells also could be found scattered across infragranular layers. In opposition to seen in CB, the immunoreactivity of CR-labeled neurons was more homogeneous. Similar to CB, distribution of CR-reactive cells was not altered across implanted areas (Fig 4B).

Parvalbumin-reactive (PV) neurons were located in all layers of the motor cortex, except in layer I. Similar to CR, there was a homogeneous pattern of neuropil labeling across all cortical layers in both implanted and contralateral hemispheres. A group of less-reactive cells could be discerned. Similar to abovementioned to CB and CR, the presence of electrode even after 6 months in the tissue did not alter the distribution of PV-reactive cells (Fig 4C).

There was no significant difference in the distribution of all groups of cells between implanted and contralateral regions among time points evaluated (Kruskal-Wallis - Bonferroni post hoc test; p>0.05) (Fig 5).

thumbnail
Fig 5. Distribution of calcium-binding proteins-reactive neurons across implanted and contralateral hemispheres.

Quantitative analysis revealed that the number of calbindin (CB)- (a), calretinin (CR)- (b) and parvalbumin (PV)-reactive neurons (c) did not differ significantly when implanted and contralateral sides were compared. Distinct colors (blue: contralateral hemisphere; green: implanted hemisphere) were adopted to provide a better identification of both control and implanted groups in all time points evaluated. The boxes correspond to the 25th and 75th percentiles (bottom and top of the boxes, respectively), the median values are indicated by the red horizontal line inside each box, the whiskers point out the minimum and maximum values and the crosses represent the outliers.

https://doi.org/10.1371/journal.pone.0130354.g005

Neuronal morphology

Chronic implants did not induce morphological alterations on inhibitory cells across implanted cortex. A qualitative analysis revealed a normal reactivity of CBP-reactive neurons (see examples in Fig 6).

thumbnail
Fig 6. Morphology of neurons reactive to calcium binding proteins (CBP) in implanted and contralateral hemispheres.

Notice that there is no evidence of alteration in both morphology and pattern of reactivity of calbindin (CB)- (a), calretinin (CR)- (b) and parvalbumin (PV)-positive neurons (c) when implanted and contralateral hemispheres are compared. Left column of the figure: implanted hemisphere; right column of the figure: contralateral hemisphere, adopted as control. Scale bar: 50 μm.

https://doi.org/10.1371/journal.pone.0130354.g006

In general, CB-highly-reactive neurons from supragranular layers had fusiform or round cell bodies, with bipolar or multipolar dendritic arborizations (Fig 6A). Neurons found in the infragranular layers were typically multipolar, with oval/round cell bodies. Less-reactive neurons from supragranular layers were normally multipolar, presenting fusiform or oval cell bodies and a proximal dendritic arborization.

The CR-reactive neurons located in supragranular layers possessed bipolar or bitufted vertically oriented somatodendritic morphology (Fig 6B), with unequivocally labeled dendrites originating from the opposite cellular poles, one of them projecting towards layer I and other projecting to layers V/VI, possessing a fusiform or oval cell body. Besides these bipolar neurons, other morphological types of neurons, mainly multipolar cells, were observed. Horizontal cells were rarely found.

PV-immunoreactive cells resembled a multipolar dendritic arborization, with an oval cell body, especially in the infragranular layers, although a few bipolar cells could also be discerned. In the supragranular layers the majority of the cell bodies were fusiform, with a multipolar dendritic arborization emerging from the cell body (Fig 6C).

Microglial response

Microglial activation was observed around the electrode tracks, mainly after 6 months of implant, appearing as a stripe of labeling circumscribing the implant site (Fig 7A). Activated microglial cells around implanted regions were characterized by hypertrophic cell bodies and thicker and shortened processes, whilst in the contralateral hemisphere microglial cells possessed a non-activated morphology, with cells presenting stellate non-hypertrophic cell bodies and thin and elongated processes (Fig 7B). Activated microglial cells were not observed far from implant sites neither in contralateral hemispheres, suggesting that electrode implants did not alter the physiology of adjacent cortical regions.

thumbnail
Fig 7. Microglial immunoreactivity across electrode tracks.

(a). Electrode implantation sites (arrows) were identified as a well-defined strip of microglial labeling, especially in latter survival time point. (b). Iba1-reactive microglial cells with a hypertrophic morphology were observed only in the vicinity of implants, whilst microglial cells presented a non-activated morphology in the contralateral hemisphere, possessing stellate non-hypertrophic cell bodies and thin and elongated processes. Activated microglial cells were not observed far from implant sites neither in contralateral hemispheres. White squares in lower magnification pictures indicate the regions where enlargements were obtained in all groups. Left column of the figure: implanted hemisphere; right column of the figure: contralateral hemisphere, adopted as control. Scale bar: 100 μm (lower magnification); 25 μm (enlargements).

https://doi.org/10.1371/journal.pone.0130354.g007

Discussion

In the present work we characterized the impact of chronic implanted tungsten multielectrode arrays on the distribution and morphology of some classes of inhibitory neurons across the rat’s motor cortex. In addition, to estimate the impact of post-implant elapsed time on neuronal recordings, we also evaluated the temporal variation of electrophysiological signals. We obtained three main findings. First, our results reinforce the notion that chronic microelectrode arrays are well tolerated by the rat cortex, with electrodes remaining functional until 6 months after implantation. Recordings exhibited a peak of high signal quality around 3 months of implant. Second, both morphology and distribution of inhibitory neurons were not affected by these chronic implants. Third, both a restricted tissue loss and microglial activation were observed solely immediately around the microwire penetration tracks.

Tissue integrity and variation of neuronal signal after chronic implants

Currently one of the main goals of the field of neuroengineering is the development of stable and compatible devices to be incorporated to the human body. The capacity of an implanted prosthesis to coexist harmonically with the host tissue without causing destructive changes is defined as biocompatibility. In line with this, distinct types of multielectrode arrays have been tested in order to evaluate their efficiency and tolerability by the nervous system [2733].

Over the past two decades, the efficiency of stainless steel and tungsten microwires, clustered in bundles or arrays, to simultaneously record neuronal populations throughout several months and even years has been demonstrated [3437]. Yet, it is still essential to perform a general characterization of the impact of the long-term presence of these microelectrodes in brain parenchyma, and also evaluate how the relationship neuronal signal/tissue preservation influences motor and cognitive tasks. In a previous study we described a small degree of tissue alteration induced by the presence of chronically implanted tungsten microelectrode arrays, including a small loss of tissue reactivity restricted to the sites of electrode implantation, and a minimal cell death around electrode tracks. Such alterations, however, did not implicate in any measurable function loss since normal physiological neuronal responses were obtained at the implanted sites [22]. Here we used a microwire somewhat thicker than our previous report (50-μm versus 35-μm) [22], with analogous results regarding tissue response, including a small loss of tissue and a restricted microglial reaction across implantation sites, what reinforces the notion that such type of array design is well tolerated by the tissue even with relatively thicker wires.

Gliosis is a physiological event triggered by minimal alterations on the cellular environment, in order to safeguard normal tissue against additional wound [38], being defined as a pathological hallmark of CNS structural injuries [39]. After a damaging event, astrocytes and microglial cells respond quickly, retracting their extensions and assuming an amoeboid-like form, originating the so-called glial scar [40]. Formation of the glial scar around the microelectrodes insulates them from nearby neurons. This is an important event in the early stages of the reaction to the microelectrode implantation because it leads to an initial improvement of extracellular signal’s selectivity [41]. Conversely, encapsulation increases the microelectrode’s impedance over time. Such event may underlie two antagonic processes, which take place at different moments in time. Initially, it may help increase the SNR, contributing to a higher neuronal yield during the first few months of the implant. Later on, however, further encapsulation of the microelectrode tip may contribute to a reduction in neuronal signal clarity [42]. This latter event might explain the decrease of neuronal signal strength we observed 6 months after implantation, given that the cortical tissue remained physiologically functional even at later stages of chronic microwire presence. In congruence with this, in a recent study our group showed that astrocytic activation increased after 6 months of implantation of 50μm electrode array as compared to 1 and 3 months of implant, but only in the region circumscribing the implantation site, defined by a cell body hypertrophy and thickening and shortening of processes [11]. In the same token, Prasad et al. (2012) described a large variation in impedance, performance, and structural changes at the microelectrode recording surface in the first 2–3 weeks post-implant, associated to a further decay of neural signal over time [43]. As both gliosis and inflammation will always occur after any tissue disturbance [4446], including chronic electrode implantation, selective control of this response becomes important, mainly because uncontrolled or generalized microglial/astroglial activation induces the generation of pro-inflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and nitric oxide (NO). These substances are all potentially harmful to nervous tissue [47,48], since they can contribute to the cell death around electrodes and, hence, total failure of recordings. However, an infiltration of peripheral macrophages after tissue disturbance cannot be entirety ruled out. Additional studies seeking for a refined identification of distinct types of immunoreactive glial cells are needed to clarify this issue.

Electrode implants and interneurons

Although GABAergic interneurons constitute a minority population within the brain, these cells play a pivotal role, seeing that they are crucial for the control of inhibition (see [4951] for reviews). Its resistance to injury is variable, depending especially on the degree and location of the lesion. Some studies point to a relative preservation of this cell group after ischemic injury and heavy metal intoxication [52,53] whereas others indicate a severe degeneration of interneurons following excitotoxicity and acute seizure [54,55]. Interneuron failure is directly involved with important brain disturbances such as schizophrenia and bipolar disorder [56,57], since a minimal disinhibition of the excitatory neurons induced by a breakdown of the inhibitory input from the GABAergic cells results in a hyperexcitability status [58].

Inhibitory interneurons display a large diversity in both their biochemical patterns and spike firing properties, what concurs to define their discrete subpopulations [59,60]. For instance, distinct classes of interneurons can be identified according to what CBP they contain. CBP major role is to buffer and transport free calcium [61]. The control of calcium levels in the nervous tissue is particularly important because cellular degeneration is widely associated to its overload, which triggers the activation of intracellular processes leading to failure of organelles and proteins and lipids, ultimately resulting in cell death [48]. Since neurons containing CBP have a greater capacity to buffer calcium, these cells might be more resistant to degeneration induced by the excessive presence of this ion. In support to this notion, previous studies have shown that CBP-reactive cells are less vulnerable to degeneration in altered states such as excitotoxicity, epileptic status and Parkinson’s disease [6265], although some works challenge this concept [66,67]. In a study evaluating CBP expression following traumatic brain injury in humans, Buritica et al. (2009) reported a variation in both reactivity and number of CPB-reactive neurons depending on the region evaluated (epicenter of the lesion or region of traumatic penumbra) [68]. Neurons found in penumbral region were relatively better preserved than those from the region primarily affected, indicating that expression of CBP is related to temporal modifications following injury, affecting the regulation of cortical excitability throughout the evolution of a severe lesion.

In the present work we observed that both the morphology and general distribution of CBP neurons were not significantly affected by the chronic implant of tungsten microwire arrays. Such result can be explained in part by the small mechanic lesion caused by the electrodes, which results in a minimal alteration in the nearby cortical cellular milieu. Given that, as previously stated, CBP cells act as calcium buffers, incidental modifications in the levels of this ion around implanted tissue could be kept under control by these interneurons [69]. In addition, microglial activation observed around implanted sites likely helps to maintain the physiology of the cellular environment after excitotoxic events (increase of free glutamate and calcium in the cortical parenchyma following the implantation of microwires) [70]. Taken together, these factors may contribute to the preservation of the integrity of the CBP interneurons even 6 months after multielectrodes array implantation.

Conclusions

During the last years a considerable progress has been achieved on BMI technology. The refinement of the techniques employed to the development of cortical neuroprosthetic devices is an extremely relevant point for the improvement of the quality of life of people suffering from restrictive body paralysis. A proper understanding of how brain responds to invasive techniques is critical, especially concerning to the preservation of the tissue functionality. As an extension of previous studies of our group [11,22], here we aimed to contribute with some additional data to this topic, by evidencing that CBP-reactive neurons were not impacted by chronic implant of tungsten arrays. Yet, more studies involving the analysis of neuronal morphology of excitatory and inhibitory cells in other cortical and subcortical areas are required in order to provide additional information to be employed on the achievement of an effective BMI rehabilitation apparatus.

Acknowledgments

The authors wish to thank two anonymous reviewers for their very constructive comments and suggestions. We also would like to thank G. Lehew for microelectrode array instruction, M. Pacheco for laboratory management, Scientific Direction of ELS-IIN for some comments and Dr. M. Nicolelis for advices and support.

Author Contributions

Conceived and designed the experiments: MAMF EM. Performed the experiments: MAMF EM JRS NAML PFC. Analyzed the data: MAMF JF JRS NAML PFC RHL EM. Contributed reagents/materials/analysis tools: JF EM PFC RHL. Wrote the paper: MAMF JF NAML EM. Design and organization of illustrations: MAMF JF. Supervision of the study: EM.

References

  1. 1. Jackson AB, Dijkers M, Devivo MJ, Poczatek RB (2004) A demographic profile of new traumatic spinal cord injuries: change and stability over 30 years. Arch Phys Med Rehabil 85(11): 1740–1748. pmid:15520968
  2. 2. Tagliaferri F, Compagnone C, Korsic M, Servadei F, Kraus J (2006) A systematic review of brain injury epidemiology in Europe. Acta Neurochir (Wien) 148(3): 255–268; discussion 268. pmid:16311842
  3. 3. DeKosky ST, Ikonomovic MD, Gandy S (2010) Traumatic brain injury—football, warfare, and long-term effects. N Engl J Med 363(14): 1293–1296. pmid:20879875
  4. 4. Freire MAM (2012) Pathophysiology of neurodegeneration following traumatic brain injury. West Indian Med J 61(7): 751–755. pmid:23620976
  5. 5. Sahler CS, Greenwald BD (2012) Traumatic brain injury in sports: a review. Rehabil Res Pract 2012: 659652. pmid:22848836
  6. 6. Finkelstein EA, Corso PS, Miller TR (2006) Incidence and economic burden of injuries in the United States. Oxford University Press. pmid:17018668
  7. 7. Rosenfeld JV, Maas AI, Bragge P, Morganti-Kossmann MC, Manley GT, Gruen RL (2012) Early management of severe traumatic brain injury. Lancet 380(9847): 1088–1098. pmid:22998718
  8. 8. Nicolelis MAL, Lebedev MA (2009) Principles of neural ensemble physiology underlying the operation of brain-machine interfaces. Nat Rev Neurosci 10(7): 530–540. pmid:19543222
  9. 9. Lebedev MA, Nicolelis MAL (2006) Brain-machine interfaces: past, present and future. Trends Neurosci 29(9): 536–546. pmid:16859758
  10. 10. de Araujo IE, Gutierrez R, Oliveira-Maia AJ, Pereira A Jr., Nicolelis MAL, Simon SA (2006) Neural ensemble coding of satiety states. Neuron 51(4): 483–494. pmid:16908413
  11. 11. Freire MAM, Faber J, Santos JR, Lemos NAM, Aratanha MA, Cavalcanti PF et al. (2015) c-Fos immunoreactivity and variation of neuronal units in rat’s motor cortex after chronic implants. IEEE 16th International Conference on eHealth Networking, Applications and Services (Healthcom 2014) 16: 18–23.
  12. 12. Vasconcelos N, Pantoja J, Belchior H, Caixeta FV, Faber J, Freire MAM et al. (2011) Cross-modal responses in the primary visual cortex encode complex objects and correlate with tactile discrimination. Proc Natl Acad Sci USA 108(37): 15408–15413. pmid:21876148
  13. 13. Gonzalez-Burgos G, Hashimoto T, Lewis DA (2007) Inhibition and timing in cortical neural circuits. Am J Psychiatry 164(1): 12. pmid:17202537
  14. 14. Mendez P, Bacci A (2011) Assortment of GABAergic plasticity in the cortical interneuron melting pot. Neural Plast 2011: 976856. pmid:21785736
  15. 15. Park HJ, Friston K (2013) Structural and functional brain networks: from connections to cognition. Science 342(6158): 1238411. pmid:24179229
  16. 16. Casanova MF (2013) Canonical circuits of the cerebral cortex as enablers of neuroprosthetics. Front Syst Neurosci 7: 77. pmid:24265606
  17. 17. DeFelipe J, Farinas I (1992) The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs. Prog Neurobiol 39(6): 563–607. pmid:1410442
  18. 18. DeFelipe J (2002) Cortical interneurons: from Cajal to 2001. Prog Brain Res 136: 215–238. pmid:12143384
  19. 19. DeFelipe J, Lopez-Cruz PL, Benavides-Piccione R, Bielza C, Larranaga P, Anderson S et al. (2013) New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat Rev Neurosci 14(3): 202–216. pmid:23385869
  20. 20. Markram H, Toledo-Rodriguez M, Wang Y, Gupta A, Silberberg G, Wu C et al. (2004) Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 5(10): 793–807. pmid:15378039
  21. 21. DeFelipe J (1997) Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J Chem Neuroanat 14(1): 1–19. pmid:9498163
  22. 22. Freire MAM, Morya E, Faber J, Santos JR, Guimaraes JS, Lemos NAM et al. (2011) Comprehensive analysis of tissue preservation and recording quality from chronic multielectrode implants. PLoS One 6(11): e27554. pmid:22096594
  23. 23. Streit WJ (2000) Microglial response to brain injury: a brief synopsis. Toxicol Pathol 28(1): 28–30. pmid:10668987
  24. 24. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates. San Diego: Academic Press 402 p.
  25. 25. Rieke F, Warland D, de Ruyter van Steveninck RR, Bialek W (1998) Spikes: exploring the neural code. MIT Press, Cambridge, USA.
  26. 26. Rozell CJ, Johnson DH (2005) Examining methods for estimating mutual information in spiking systems. Neurocomputing 65: 429–434.
  27. 27. Griffith RW, Humphrey DR (2006) Long-term gliosis around chronically implanted platinum electrodes in the Rhesus macaque motor cortex. Neurosci Lett 406(1–2): 81–86.
  28. 28. Tsytsarev V, Taketani M, Schottler F, Tanaka S, Hara M (2006) A new planar multielectrode array: recording from a rat auditory cortex. J Neural Eng 3(4): 293–298. pmid:17124333
  29. 29. Stice P, Muthuswamy J (2009) Assessment of gliosis around moveable implants in the brain. J Neural Eng 6(4): 046004. pmid:19556680
  30. 30. Rao L, Zhou H, Li T, Li C, Duan YY (2012) Polyethylene glycol-containing polyurethane hydrogel coatings for improving the biocompatibility of neural electrodes. Acta Biomater 8(6): 2233–2242. pmid:22406507
  31. 31. Lind G, Linsmeier CE, Schouenborg J (2013) The density difference between tissue and neural probes is a key factor for glial scarring. Sci Rep 3: 2942. pmid:24127004
  32. 32. Prasad A, Xue QS, Dieme R, Sankar V, Mayrand RC, Nishida T et al. (2014) Abiotic-biotic characterization of Pt/Ir microelectrode arrays in chronic implants. Front Neuroeng 7: 2. pmid:24550823
  33. 33. Kohler P, Wolff A, Ejserholm F, Wallman L, Schouenborg J, Linsmeier CE (2015) Influence of probe flexibility and gelatin embedding on neuronal density and glial responses to brain implants. PLoS One 10(3): e0119340. pmid:25790172
  34. 34. Nicolelis MAL, Lin RC, Woodward DJ, Chapin JK (1993) Dynamic and distributed properties of many-neuron ensembles in the ventral posterior medial thalamus of awake rats. Proc Natl Acad Sci USA 90(6): 2212–2216. pmid:8460124
  35. 35. Nicolelis MAL, Baccala LA, Lin RC, Chapin JK (1995) Sensorimotor encoding by synchronous neural ensemble activity at multiple levels of the somatosensory system. Science 268(5215): 1353–1358. pmid:7761855
  36. 36. Nicolelis MAL, Dimitrov D, Carmena JM, Crist R, Lehew G, Kralik JD et al. (2003) Chronic, multisite, multielectrode recordings in macaque monkeys. Proc Natl Acad Sci USA 100(19): 11041–11046. pmid:12960378
  37. 37. Santana MB, Halje P, Simplicio H, Richter U, Freire MAM, Petersson P et al. (2014) Spinal cord stimulation alleviates motor deficits in a primate model of Parkinson disease. Neuron 84(4): 716–722. pmid:25447740
  38. 38. Pekny M, Nilsson M (2005) Astrocyte activation and reactive gliosis. Glia 50(4): 427–434. pmid:15846805
  39. 39. Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119(1): 7–35. pmid:20012068
  40. 40. Stichel CC, Muller HW (1998) The CNS lesion scar: new vistas on an old regeneration barrier. Cell Tissue Res 294(1): 1–9. pmid:9724451
  41. 41. Kralik JD, Dimitrov DF, Krupa DJ, Katz DB, Cohen D, Nicolelis MAL (2001) Techniques for long-term multisite neuronal ensemble recordings in behaving animals. Methods 25(2): 121–150. pmid:11812202
  42. 42. Rothschild RM (2010) Neuroengineering tools/applications for bidirectional interfaces, brain-computer interfaces, and neuroprosthetic implants—a review of recent progress. Front Neuroeng 3: 112. pmid:21060801
  43. 43. Prasad A, Xue QS, Sankar V, Nishida T, Shaw G, Streit WJ et al. (2012) Comprehensive characterization and failure modes of tungsten microwire arrays in chronic neural implants. J Neural Eng 9(5): 056015. pmid:23010756
  44. 44. Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T (2002) Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care 8(2): 101–105. pmid:12386508
  45. 45. Guimaraes JS, Freire MAM, Lima RR, Picanço-Diniz CW, Pereira A, Gomes-Leal W (2010) Minocycline treatment reduces white matter damage after excitotoxic striatal injury. Brain Res 1329: 182–193. pmid:20226770
  46. 46. Santos JR, Gois AM, Mendonca DM, Freire MAM (2014) Nutritional status, oxidative stress and dementia: the role of selenium in Alzheimer's disease. Front Aging Neurosci 6: 206. pmid:25221506
  47. 47. Allan SM, Rothwell NJ (2001) Cytokines and acute neurodegeneration. Nat Rev Neurosci 2(10): 734–744. pmid:11584311
  48. 48. Guimaraes JS, Freire MAM, Lima RR, Souza-Rodrigues RD, Costa AM, dos Santos CD et al. (2009) Mechanisms of secondary degeneration in the central nervous system during acute neural disorders and white matter damage. Rev Neurol 48(6): 304–310. pmid:19291655
  49. 49. Freund TF, Buzsaki G (1996) Interneurons of the hippocampus. Hippocampus 6(4): 347–470. pmid:8915675
  50. 50. Druga R (2009) Neocortical inhibitory system. Folia Biol (Praha) 55(6): 201–217. pmid:20163769
  51. 51. Kepecs A, Fishell G (2014) Interneuron cell types are fit to function. Nature 505(7483): 318–326. pmid:24429630
  52. 52. Frahm C, Haupt C, Witte OW (2004) GABA neurons survive focal ischemic injury. Neuroscience 127(2): 341–346. pmid:15262324
  53. 53. Freire MAM, Oliveira RB, Picanço-Diniz CW, Pereira A Jr. (2007) Differential effects of methylmercury intoxication in the rat's barrel field as evidenced by NADPH diaphorase histochemistry. Neurotoxicology 28(1): 175–181. pmid:16930717
  54. 54. Shetty AK, Hattiangady B, Rao MS (2009) Vulnerability of hippocampal GABA-ergic interneurons to kainate-induced excitotoxic injury during old age. J Cell Mol Med 13(8B): 2408–2423. pmid:20141618
  55. 55. Kuruba R, Hattiangady B, Parihar VK, Shuai B, Shetty AK (2014) Differential susceptibility of interneurons expressing neuropeptide Y or parvalbumin in the aged hippocampus to acute seizure activity. PLoS One 6(9): e24493.
  56. 56. Eyles DW, McGrath JJ, Reynolds GP (2002) Neuronal calcium-binding proteins and schizophrenia. Schizophr Res 57(1): 27–34. pmid:12165373
  57. 57. Sakai T, Oshima A, Nozaki Y, Ida I, Haga C, Akiyama H et al. (2008) Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder. Neuropathology 28(2): 143–150. pmid:18069969
  58. 58. Buzsaki G, Geisler C, Henze DA, Wang XJ (2004) Interneuron Diversity series: Circuit complexity and axon wiring economy of cortical interneurons. Trends Neurosci 27(4): 186–193. pmid:15046877
  59. 59. Cauli B, Audinat E, Lambolez B, Angulo MC, Ropert N, Tsuzuki K et al. (1997) Molecular and physiological diversity of cortical nonpyramidal cells. J Neurosci 17(10): 3894–3906. pmid:9133407
  60. 60. Gonchar Y, Wang Q, Burkhalter A (2007) Multiple distinct subtypes of GABAergic neurons in mouse visual cortex identified by triple immunostaining. Front Neuroanat 1: 3. pmid:18958197
  61. 61. Heizmann CW (1993) Calcium signaling in the brain. Acta Neurobiol Exp 53(1): 15–23. pmid:8317243
  62. 62. Leranth C, Ribak CE (1991) Calcium-binding proteins are concentrated in the CA2 field of the monkey hippocampus: a possible key to this region's resistance to epileptic damage. Exp Brain Res 85(1): 129–136. pmid:1884753
  63. 63. German DC, Manaye KF, Sonsalla PK, Brooks BA (1992) Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Ann N Y Acad Sci 648: 42–62. pmid:1353337
  64. 64. Lukas W, Jones KA (1994) Cortical neurons containing calretinin are selectively resistant to calcium overload and excitotoxicity in vitro. Neuroscience 61(2): 307–316. pmid:7969911
  65. 65. McMahon A, Wong BS, Iacopino AM, Ng MC, Chi S, German DC (1998) Calbindin-D28k buffers intracellular calcium and promotes resistance to degeneration in PC12 cells. Mol Brain Res 54(1): 56–63. pmid:9526044
  66. 66. Iacopino AM, Christakos S (1990) Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc Natl Acad Sci USA 87(11): 4078–4082. pmid:2140897
  67. 67. Mockel V, Fischer G (1994) Vulnerability to excitotoxic stimuli of cultured rat hippocampal neurons containing the calcium-binding proteins calretinin and calbindin D28K. Brain Res 648(1): 109–120. pmid:7922513
  68. 68. Buritica E, Villamil L, Guzman F, Escobar MI, Garcia-Cairasco N, Pimienta HJ (2009) Changes in calcium-binding protein expression in human cortical contusion tissue. J Neurotrauma 26(12): 2145–2155. pmid:19645526
  69. 69. Mattson MP, Rychlik B, Chu C, Christakos S (1991) Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons. Neuron 6(1): 41–51. pmid:1670921
  70. 70. Schousboe A, Waagepetersen HS (2005) Role of astrocytes in glutamate homeostasis: implications for excitotoxicity. Neurotox Res 8(3–4): 221–225. pmid:16371324